位置:首页 > 蛋白库 > DPOL_HBVD3
DPOL_HBVD3
ID   DPOL_HBVD3              Reviewed;         832 AA.
AC   P03156; P04484;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   03-AUG-2022, entry version 111.
DE   RecName: Full=Protein P {ECO:0000255|HAMAP-Rule:MF_04073};
DE   Includes:
DE     RecName: Full=DNA-directed DNA polymerase {ECO:0000255|HAMAP-Rule:MF_04073};
DE              EC=2.7.7.7 {ECO:0000255|HAMAP-Rule:MF_04073};
DE   Includes:
DE     RecName: Full=RNA-directed DNA polymerase {ECO:0000255|HAMAP-Rule:MF_04073};
DE              EC=2.7.7.49 {ECO:0000255|HAMAP-Rule:MF_04073};
DE   Includes:
DE     RecName: Full=Ribonuclease H {ECO:0000255|HAMAP-Rule:MF_04073};
DE              EC=3.1.26.4 {ECO:0000255|HAMAP-Rule:MF_04073};
GN   Name=P {ECO:0000255|HAMAP-Rule:MF_04073};
OS   Hepatitis B virus genotype D subtype ayw (isolate France/Tiollais/1979)
OS   (HBV-D).
OC   Viruses; Riboviria; Pararnavirae; Artverviricota; Revtraviricetes;
OC   Blubervirales; Hepadnaviridae; Orthohepadnavirus;
OC   hepatitis B virus genotype D.
OX   NCBI_TaxID=490133;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
OH   NCBI_TaxID=9598; Pan troglodytes (Chimpanzee).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=399327; DOI=10.1038/281646a0;
RA   Galibert F., Mandart E., Fitoussi F., Tiollais P., Charnay P.;
RT   "Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned
RT   in E. coli.";
RL   Nature 281:646-650(1979).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Latvia;
RX   PubMed=3996597; DOI=10.1016/0014-5793(85)80771-7;
RA   Bichko V., Pushko P., Dreilina D., Pumpen P., Gren E.Y.;
RT   "Subtype ayw variant of hepatitis B virus. DNA primary structure
RT   analysis.";
RL   FEBS Lett. 185:208-212(1985).
RN   [3]
RP   REVIEW.
RX   PubMed=17206754; DOI=10.3748/wjg.v13.i1.48;
RA   Beck J., Nassal M.;
RT   "Hepatitis B virus replication.";
RL   World J. Gastroenterol. 13:48-64(2007).
CC   -!- FUNCTION: Multifunctional enzyme that converts the viral RNA genome
CC       into dsDNA in viral cytoplasmic capsids. This enzyme displays a DNA
CC       polymerase activity that can copy either DNA or RNA templates, and a
CC       ribonuclease H (RNase H) activity that cleaves the RNA strand of RNA-
CC       DNA heteroduplexes in a partially processive 3'- to 5'-endonucleasic
CC       mode. Neo-synthesized pregenomic RNA (pgRNA) are encapsidated together
CC       with the P protein, and reverse-transcribed inside the nucleocapsid.
CC       Initiation of reverse-transcription occurs first by binding the epsilon
CC       loop on the pgRNA genome, and is initiated by protein priming, thereby
CC       the 5'-end of (-)DNA is covalently linked to P protein. Partial (+)DNA
CC       is synthesized from the (-)DNA template and generates the relaxed
CC       circular DNA (RC-DNA) genome. After budding and infection, the RC-DNA
CC       migrates in the nucleus, and is converted into a plasmid-like
CC       covalently closed circular DNA (cccDNA). The activity of P protein does
CC       not seem to be necessary for cccDNA generation, and is presumably
CC       released from (+)DNA by host nuclear DNA repair machinery.
CC       {ECO:0000255|HAMAP-Rule:MF_04073}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339,
CC         Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:173112; EC=2.7.7.7; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_04073};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339,
CC         Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:173112; EC=2.7.7.49; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_04073};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endonucleolytic cleavage to 5'-phosphomonoester.; EC=3.1.26.4;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_04073};
CC   -!- ACTIVITY REGULATION: Activated by host HSP70 and HSP40 in vitro to be
CC       able to bind the epsilon loop of the pgRNA. Because deletion of the
CC       RNase H region renders the protein partly chaperone-independent, the
CC       chaperones may be needed indirectly to relieve occlusion of the RNA-
CC       binding site by this domain. Inhibited by several reverse-transcriptase
CC       inhibitors: Lamivudine, Adefovir and Entecavir. {ECO:0000255|HAMAP-
CC       Rule:MF_04073}.
CC   -!- DOMAIN: Terminal protein domain (TP) is hepadnavirus-specific. Spacer
CC       domain is highly variable and separates the TP and RT domains.
CC       Polymerase/reverse-transcriptase domain (RT) and ribonuclease H domain
CC       (RH) are similar to retrovirus reverse transcriptase/RNase H.
CC       {ECO:0000255|HAMAP-Rule:MF_04073}.
CC   -!- DOMAIN: The polymerase/reverse transcriptase (RT) and ribonuclease H
CC       (RH) domains are structured in five subdomains: finger, palm, thumb,
CC       connection and RNase H. Within the palm subdomain, the 'primer grip'
CC       region is thought to be involved in the positioning of the primer
CC       terminus for accommodating the incoming nucleotide. The RH domain
CC       stabilizes the association of RT with primer-template.
CC       {ECO:0000255|HAMAP-Rule:MF_04073}.
CC   -!- MISCELLANEOUS: Hepadnaviral virions contain probably just one P protein
CC       molecule per particle. {ECO:0000255|HAMAP-Rule:MF_04073}.
CC   -!- SIMILARITY: Belongs to the hepadnaviridae P protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04073}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; V01460; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X02496; CAB41700.1; -; Genomic_DNA.
DR   PIR; A00702; JDVLVA.
DR   PIR; A00703; JDVLVB.
DR   Proteomes; UP000007930; Genome.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniRule.
DR   GO; GO:0039503; P:suppression by virus of host innate immune response; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.70.270; -; 1.
DR   HAMAP; MF_04073; HBV_DPOL; 1.
DR   InterPro; IPR043502; DNA/RNA_pol_sf.
DR   InterPro; IPR001462; DNApol_viral_C.
DR   InterPro; IPR000201; DNApol_viral_N.
DR   InterPro; IPR037531; HBV_DPOL.
DR   InterPro; IPR043128; Rev_trsase/Diguanyl_cyclase.
DR   InterPro; IPR000477; RT_dom.
DR   Pfam; PF00336; DNA_pol_viral_C; 1.
DR   Pfam; PF00242; DNA_pol_viral_N; 1.
DR   Pfam; PF00078; RVT_1; 1.
DR   SUPFAM; SSF56672; SSF56672; 1.
DR   PROSITE; PS50878; RT_POL; 1.
PE   3: Inferred from homology;
KW   DNA replication; DNA-binding; DNA-directed DNA polymerase; Endonuclease;
KW   Host-virus interaction; Hydrolase;
KW   Inhibition of host innate immune response by virus;
KW   Inhibition of host RLR pathway by virus; Magnesium; Metal-binding;
KW   Multifunctional enzyme; Nuclease; Nucleotidyltransferase;
KW   Reference proteome; RNA-directed DNA polymerase; Transferase;
KW   Viral immunoevasion.
FT   CHAIN           1..832
FT                   /note="Protein P"
FT                   /id="PRO_0000222344"
FT   DOMAIN          346..589
FT                   /note="Reverse transcriptase"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04073"
FT   REGION          1..177
FT                   /note="Terminal protein domain (TP)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04073"
FT   REGION          178..335
FT                   /note="Spacer"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04073"
FT   REGION          186..225
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          336..679
FT                   /note="Polymerase/reverse transcriptase domain (RT)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04073"
FT   BINDING         418
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04073"
FT   BINDING         540
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04073"
FT   BINDING         541
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04073"
FT   SITE            63
FT                   /note="Priming of reverse-transcription by covalently
FT                   linking the first nucleotide of the (-)DNA"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04073"
FT   VARIANT         118
FT                   /note="K -> N (in strain: Latvia)"
FT   VARIANT         136
FT                   /note="H -> Y (in strain: Latvia)"
FT   VARIANT         178
FT                   /note="D -> E (in strain: Latvia)"
FT   VARIANT         236
FT                   /note="F -> I (in strain: Latvia)"
FT   VARIANT         240
FT                   /note="A -> T (in strain: Latvia)"
FT   VARIANT         255..257
FT                   /note="TNF -> RNV (in strain: Latvia)"
FT   VARIANT         266
FT                   /note="H -> Y (in strain: Latvia)"
FT   VARIANT         293
FT                   /note="F -> L (in strain: Latvia)"
FT   VARIANT         330
FT                   /note="L -> H (in strain: Latvia)"
FT   VARIANT         356
FT                   /note="S -> A (in strain: Latvia)"
FT   VARIANT         457..459
FT                   /note="LNN -> FNY (in strain: Latvia)"
FT   VARIANT         465..466
FT                   /note="PD -> QN (in strain: Latvia)"
FT   VARIANT         470
FT                   /note="Y -> S (in strain: Latvia)"
FT   VARIANT         583
FT                   /note="N -> H (in strain: Latvia)"
FT   VARIANT         598
FT                   /note="E -> D (in strain: Latvia)"
FT   VARIANT         613
FT                   /note="I -> V (in strain: Latvia)"
FT   VARIANT         709..711
FT                   /note="SAP -> LAR (in strain: Latvia)"
FT   VARIANT         734
FT                   /note="I -> L (in strain: Latvia)"
FT   VARIANT         749
FT                   /note="F -> Y (in strain: Latvia)"
SQ   SEQUENCE   832 AA;  93677 MW;  7AB3AAE58A57D0D6 CRC64;
     MPLSYQHFRR LLLLDDEAGP LEEELPRLAD EGLNRRVAED LNLGNLNVSI PWTHKVGNFT
     GLYSSTVPVF NPHWKTPSFP NIHLHQDIIK KCEQFVGPLT VNEKRRLQLI MPARFYPKVT
     KYLPLDKGIK PYYPEHLVNH YFQTRHYLHT LWKAGILYKR ETTHSASFCG SPYSWEQDLQ
     HGAESFHQQS SGILSRPPVG SSLQSKHRKS RLGLQSQQGH LARRQQGRSW SIRAGFHPTA
     RRPFGVEPSG SGHTTNFASK SASCLHQSPV RKAAYPAVST FEKHSSSGHA VEFHNLPPNS
     ARSQSERPVF PCWWLQFRNS KPCSDYCLSL IVNLLEDWGP CAEHGEHHIR IPRTPSRVTG
     GVFLVDKNPH NTAESRLVVD FSQFSRGNYR VSWPKFAVPN LQSLTNLLSS NLSWLSLDVS
     AAFYHLPLHP AAMPHLLVGS SGLSRYVARL SSNSRILNNQ HGTMPDLHDY CSRNLYVSLL
     LLYQTFGRKL HLYSHPIILG FRKIPMGVGL SPFLLAQFTS AICSVVRRAF PHCLAFSYMD
     DVVLGAKSVQ HLESLFTAVT NFLLSLGIHL NPNKTKRWGY SLNFMGYVIG CYGSLPQEHI
     IQKIKECFRK LPINRPIDWK VCQRIVGLLG FAAPFTQCGY PALMPLYACI QSKQAFTFSP
     TYKAFLCKQY LNLYPVARQR PGLCQVFADA TPTGWGLVMG HQRMRGTFSA PLPIHTAELL
     AACFARSRSG ANIIGTDNSV VLSRKYTSFP WLLGCAANWI LRGTSFVYVP SALNPADDPS
     RGRLGLSRPL LRLPFRPTTG RTSLYADSPS VPSHLPDRVH FASPLHVAWR PP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024